Dr. Kumar is currently a Professor of Biochemistry at The Commonwealth Medical College (TCMC), Scranton, PA, USA. He received his Ph.D. from University of Lucknow, Lucknow, India, and post doctoral training at University of Texas Medical Branch (UTMB), Galveston, TX, USA. Before moving to TCMC, he held position of Associate Professor in the Department of Internal Medicine at UTMB. Dr. Kumar’s area of research is focused on the therapeutic targeting of the steroid hormone receptors (SHRs) for endocrine-related diseases. Currently, his laboratory is integrating multiple complementary state-of-art technologies add a new “translational” goal of targeting SHRs’ intrinsically disordered N-terminal activation function domain, AF1 as a novel therapeutic strategy that could provide additional selectivity needed to target cell-tissue specific gene regulations in current endocrine-based therapies. Dr. Kumar has served as an editorial board member of more than two-dozen international peer-reviewed scientific journals and as scientific reviewer for more than 50 peer-reviewed journals. He has also served on numerous national and international scientific grant review panels. He has over 100 publications including highly reputed peer-reviewed scientific journals, books, book chapters, and a patent, and has been invited to speak at several international scientific meetings and research institutes/universities.

Endocrinology; Cardiovascular diseases; Cancer; Protein structure and functions; Macromolecular interactions; Cell signaling and Gene regulation; Steroid hormone receptors; Post translational modifications;